Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessartery development

DDIT3 PCDHA10

1.44e-0313392GO:0060840
GeneOntologyBiologicalProcessbone mineralization

SRGN RSPO2

1.81e-0314992GO:0030282
GeneOntologyBiologicalProcessbiomineral tissue development

SRGN RSPO2

3.32e-0320392GO:0031214
GeneOntologyBiologicalProcessmaintenance of location in cell

SRGN DDIT3

5.33e-0325992GO:0051651
GeneOntologyBiologicalProcessregulation of canonical Wnt signaling pathway

DDIT3 RSPO2

6.42e-0328592GO:0060828
CoexpressionGSE22886_TCELL_VS_BCELL_NAIVE_UP

SRGN TBCD THYN1

3.50e-0519993M4425
CoexpressionGSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP

SRGN DDIT3 THYN1

3.55e-0520093M6005
CoexpressionBUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN

SRGN ACP6 THYN1

1.13e-0364793M10351
CoexpressionTABULA_MURIS_SENIS_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING

SRGN ACP6 THYN1

1.55e-0372393MM3672
CoexpressionZHANG_UTERUS_C12_MONOCYTE

SRGN DDIT3

1.78e-0318892MM16618
CoexpressionGSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN

DDIT3 ACP6

1.92e-0319592M5353
CoexpressionGSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_UP

ACP6 TBCD

1.93e-0319692M7247
CoexpressionGSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP

ACP6 PCDHA10

1.97e-0319892M5584
CoexpressionGSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_DN

SRGN TBCD

1.97e-0319892M6277
CoexpressionGSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN

TBCD THYN1

1.97e-0319892M6118
CoexpressionGSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN

TBCD THYN1

1.97e-0319892M6114
CoexpressionGSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN

SRGN DDIT3

1.99e-0319992M8313
CoexpressionGSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_DN

ACP6 THYN1

1.99e-0319992M8571
CoexpressionGSE22886_CD4_TCELL_VS_BCELL_NAIVE_UP

SRGN TBCD

1.99e-0319992M4430
CoexpressionGSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_UP

DDIT3 RSPO2

1.99e-0319992M8080
CoexpressionGSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP

AQR ACP6

1.99e-0319992M9750
CoexpressionGSE3982_EOSINOPHIL_VS_DC_UP

DDIT3 THYN1

1.99e-0319992M5399
CoexpressionGSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN

AQR ACP6

1.99e-0319992M6538
CoexpressionGSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_UP

ACP6 THYN1

1.99e-0319992M3052
CoexpressionGSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP

ACP6 THYN1

1.99e-0319992M3050
CoexpressionGSE3982_DC_VS_BASOPHIL_DN

DDIT3 THYN1

1.99e-0319992M5473
CoexpressionGSE14769_UNSTIM_VS_240MIN_LPS_BMDM_UP

ACP6 THYN1

2.01e-0320092M3507
CoexpressionGSE14769_UNSTIM_VS_360MIN_LPS_BMDM_UP

ACP6 THYN1

2.01e-0320092M3509
CoexpressionGSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN

SRGN DDIT3

2.01e-0320092M8306
CoexpressionGSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_UP

DDIT3 PCDHA10

2.01e-0320092M9633
CoexpressionGSE31082_DP_VS_CD8_SP_THYMOCYTE_DN

SRGN AQR

2.01e-0320092M5068
CoexpressionGSE43955_1H_VS_10H_ACT_CD4_TCELL_DN

RSPO2 PCDHA10

2.01e-0320092M9659
CoexpressionGSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_UP

SRGN DDIT3

2.01e-0320092M8112
CoexpressionGSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN

DDIT3 PCDHA10

2.01e-0320092M9677
CoexpressionGSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN

SRGN AQR

2.01e-0320092M7271
CoexpressionGSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_DN

DDIT3 THYN1

2.01e-0320092M6892
CoexpressionGSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_UP

SRGN DDIT3

2.01e-0320092M5102
CoexpressionGSE11924_TFH_VS_TH17_CD4_TCELL_DN

AQR ACP6

2.01e-0320092M3157
CoexpressionGSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_UP

SRGN THYN1

2.01e-0320092M8638
CoexpressionGSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_UP

DDIT3 AQR

2.01e-0320092M7794
CoexpressionGSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_UP

AQR TBCD

2.01e-0320092M3780
CoexpressionGSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_DN

SRGN DDIT3

2.01e-0320092M6630
CoexpressionGSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN

SRGN DDIT3

2.01e-0320092M6000
CoexpressionGSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP

SRGN DDIT3

2.01e-0320092M9770
CoexpressionGSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN

SRGN RSPO2

2.01e-0320092M9560
CoexpressionGOLDRATH_EFF_VS_MEMORY_CD8_TCELL_DN

DDIT3 ACP6

2.01e-0320092M3044
CoexpressionGSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_DN

ACP6 THYN1

2.01e-0320092M8966
CoexpressionGSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_DN

SRGN DDIT3

2.01e-0320092M5603
CoexpressionGSE24142_DN2_VS_DN3_THYMOCYTE_UP

SRGN THYN1

2.01e-0320092M4555
CoexpressionGSE1460_DP_VS_CD4_THYMOCYTE_UP

TBCD THYN1

2.01e-0320092M3452
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SRGN DDIT3

2.19e-0411292ef8fdb35a4d295f7e4a0a4029e5965c1f17e413a
ToppCellPND10-Immune-Immune_Myeloid-Granulocytic-Mast|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SRGN DDIT3

4.45e-04160926393e3d5c5c8176c93aecd89b313bd054a00d474
ToppCell356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SRGN RSPO2

4.45e-04160920293b244c063a62819690bf22bbc2681f8d15252
ToppCell356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SRGN RSPO2

4.45e-04160923eaae86fa08f7651021316f8e5811bf48055591e
ToppCellPND10-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SRGN DDIT3

4.45e-04160922065938e944eb99478fd8132c2c03adeaee6d447
ToppCellsevere_COVID-19-Neutrophil|World / disease group, cell group and cell class (v2)

SRGN DDIT3

5.02e-0417092dfc807e0dd66179490a258ecbe8eb439e715799d
ToppCellsevere_COVID-19-Neutrophil|severe_COVID-19 / disease group, cell group and cell class (v2)

SRGN DDIT3

5.14e-04172928f4bcb9b2bbf8b4333f673d8ad6bb88dfda4792a
ToppCellBAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SRGN DDIT3

5.20e-04173925b76d9cc56bbb29017e64a2d0a3c76c0be003d96
ToppCellBAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SRGN DDIT3

5.20e-0417392bf685025961e79b379f2c35464b6c8ce3e31ace0
ToppCellcritical-Epithelial-unknown_epithelial|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

SRGN DDIT3

5.20e-04173924144b1cdefa8c37b6ac7a6d249fa5292ffb2b8b2
ToppCellBAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SRGN DDIT3

5.20e-04173921edef5aeab626cbf2c09468e77b02cfa2d21ba03
ToppCellBAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SRGN DDIT3

5.20e-0417392a6e73a40b0d5356564a594053e772f9d061a5919
ToppCellBAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SRGN DDIT3

5.20e-0417392c37dba3804df7c3151e18e6ae4e0b6e7a92bae97
ToppCellBAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SRGN DDIT3

5.20e-0417392a8b5370f4c893a20c58e97659f3ac168699693f8
ToppCellsaliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SRGN ACP6

5.26e-0417492d77fa525d5c87c190b4a10787b270eabd16c610f
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type.

DDIT3 ACP6

5.32e-04175922812ac2ef41d245db544697fb6da1883361c96e8
ToppCell356C-Lymphocytic-ILC|356C / Donor, Lineage, Cell class and subclass (all cells)

SRGN TBCD

5.32e-04175927fa8330ce813c48bd332be618909e5ec8d0f5d7e
ToppCellSevere_COVID-19-Myeloid-Neutrophil|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）

SRGN DDIT3

5.44e-0417792a6fae376f1beb1df423484d9b1bd1d954ca117af
ToppCellE16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SRGN DDIT3

5.44e-04177924bc100062891d07cacd10ffba38966cc6302c92f
ToppCellE16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SRGN DDIT3

5.44e-04177929f3a2adb9cd4f0a059afc87b6e377a9702154bb1
ToppCellE16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SRGN DDIT3

5.44e-041779284591e28482ab62a5ef41e61043eb64912766356
ToppCellSevere-Myeloid-Neutrophil|Severe / Condition, Lineage, Cell class and cell subclass

SRGN DDIT3

5.50e-0417892454313efe59d71e7327b9758efabf2d893e4a8fd
ToppCellSevere-Myeloid-Neutrophil-|Severe / Condition, Lineage, Cell class and cell subclass

SRGN DDIT3

5.50e-04178928618ae891d62bf70fe860ff7bb2d31868961aa13
ToppCell(3)_Chondrocytes-(32)_Chondro-prehyper-2|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis

SRGN DDIT3

5.63e-0418092708a5c89b9337e281fce4f482892a1c1766c7812
ToppCellE18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SRGN DDIT3

5.63e-0418092ca2a35bfb67347e47f511589a3d0f763e6664634
ToppCellE18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SRGN DDIT3

5.63e-04180924e9e8cde2919610c4ac0025b1c9819808048bc1d
ToppCellE18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SRGN DDIT3

5.63e-0418092466381bf93c3da6a2a241daadb68e9aad2964eae
ToppCell3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SRGN TBCD

5.63e-0418092efc4c5a4dea456527526bbfd88cf70d803893671
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

SRGN DDIT3

5.75e-0418292f9c013075477e77a8373c73301a51e7e3f35369c
ToppCell3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_Myeloid|bone_marrow / Manually curated celltypes from each tissue

SRGN RSPO2

5.75e-04182926745d464c3ff289726aa8164e9a43f407f8e4380
ToppCellCF-Myeloid-Neutrophil|CF / Disease state, Lineage and Cell class

SRGN ACP6

5.81e-0418392da43827952e6fdee2ce94648c316182f272b321c
ToppCellNS-moderate-d_07-13-Myeloid-Neutrophil|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

SRGN DDIT3

5.88e-04184924c7d05f1a4556b13cedbaaf88d67ac32d09b109b
ToppCellmild-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

SRGN DDIT3

5.88e-04184921a0e8b20b3ac8416d05c2d5934ab4ac80be4cce5
ToppCellPBMC-Mild-cDC_8|Mild / Compartment, Disease Groups and Clusters

SRGN DDIT3

5.94e-0418592891b39c20fe9858fbba90d9ef7a253f1a0870211
ToppCellInfluenza-Influenza_Severe-Myeloid-Neutrophil|Influenza_Severe / Disease, condition lineage and cell class

SRGN ACP6

6.00e-04186921dfcec9196d4db76fba3abc74e85885b1fb98b87
ToppCell3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SRGN RSPO2

6.07e-0418792d69f4eee0304a7db226275ab77fc9d5d2b6f3a07
ToppCellcontrol-Myeloid-Neutrophils_4|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

SRGN DDIT3

6.13e-041889222d76c222fb0e3da08e10191af0090f14e03f2ad
ToppCell3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SRGN DDIT3

6.20e-0418992d26af19fd7e0c7eb78a5a3a245ca5229c4e9e847
ToppCell(5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)

SRGN RSPO2

6.26e-041909271e112dfb8c3190fe0286b45a046ea789eb6a8db
ToppCellmetastatic_Lymph_Node-T/NK_cells-Exhausted_CD8+_T|metastatic_Lymph_Node / Location, Cell class and cell subclass

SRGN TBCD

6.26e-0419092cb4cf8ae2156c20b7978ae2e55aa605b4e90f455
ToppCellsaliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SRGN DDIT3

6.33e-041919247156e5f1d790707f42f6283104a44b33af613e5
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

SRGN PCDHA10

6.33e-04191929bb6a6b88f351217455765ba07a6acf11fda98f4
ToppCellcontrol-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

SRGN DDIT3

6.33e-0419192db1b3cd07d7d190155b2d14e82e1d124975fbd0b
ToppCellmetastatic_Lymph_Node-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass

SRGN TBCD

6.39e-04192925841378789d8267f94071df060debc9171700784
ToppCellASK454|World / Donor, Lineage and Cell class of Lung cells from Dropseq

SRGN DDIT3

6.39e-04192926b047b445a0df0ecdd6d7baf388a0d966a93b3a2
ToppCellControl-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class

SRGN RSPO2

6.46e-04193925896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCellfacs-Heart-RV-18m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ACP6 TBCD

6.46e-041939277bc4353a1e9eae32bc6beb333577ba0294a10fc
ToppCellfacs-Heart-RV-18m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ACP6 TBCD

6.46e-0419392b9b431c18c81c616069a546cded4753563a1e701
ToppCellnormal_Pleural_Fluid-T/NK_cells-Exhausted_CD8+_T|normal_Pleural_Fluid / Location, Cell class and cell subclass

SRGN TBCD

6.53e-041949268a9e00c9e1a855eeebfc26c038652f3800758db
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

SRGN DDIT3

6.53e-0419492744fd4580942183a1058717d0c3ac86483e366ed
ToppCell368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SRGN RSPO2

6.53e-0419492d9eec28fa7b255c0ec023276dd955f1e276e7159
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

SRGN DDIT3

6.53e-0419492b04cbd240c59755ef7bdeb17fee3028caef6dedb
ToppCellmetastatic_Lymph_Node-T/NK_cells-CD4+_Th|metastatic_Lymph_Node / Location, Cell class and cell subclass

SRGN TBCD

6.53e-04194921ce9b4c1fbdbc5e39c03adf7ffba3d0efea81862
ToppCellmild-Myeloid-Neutrophils_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

SRGN DDIT3

6.53e-0419492ccd911ce3251cd1c60f1fb2ce00650fbe7a379bb
ToppCell368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SRGN RSPO2

6.53e-0419492e4d7e9709ce42d4610e44d3445927eefbcbb9eff
ToppCelltumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass

SRGN TBCD

6.53e-04194927b8fe5b702b99aac5bff7de8ac0b5cabb3235b56
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

SRGN DDIT3

6.53e-0419492d2f6c8900b5c448eede8047ca964e94b19bd6ca5
ToppCelltumor_Lung-T/NK_cells-Exhausted_CD8+_T|tumor_Lung / Location, Cell class and cell subclass

SRGN TBCD

6.53e-04194923fdcfd04174e39491d4f1e6276acc9d11e5a4345
ToppCellsaliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

TBCD THYN1

6.59e-04195924b9663509cc5e3f409f6d0d37640cb301a827d98
ToppCelltumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_CD8+_T|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

SRGN TBCD

6.59e-0419592f2029195d5b655120a9e84074b2583e2d89c0a1d
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SRGN DDIT3

6.59e-0419592fa8ac154e5aebc26463ff84f0ad1038095770bc6
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SRGN DDIT3

6.59e-0419592562e4c0e4e81f6303e57b846da71d1667fc35963
ToppCellcontrol-Myeloid-Neutrophils_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

SRGN DDIT3

6.66e-04196929c8623232c47af5de9f360fd5c5113362e37c6c9
ToppCellsaliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SRGN DDIT3

6.66e-0419692d9b5eaca4089d5337f1175a663418c9c675cdd87
ToppCelllymphoid-T_cell-unlabelled(multiplets)|World / Lineage, cell class and subclass

SRGN DDIT3

6.66e-041969278b006922307c154622d71fcbc79ae5eed3f4b23
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SRGN TBCD

6.66e-0419692145fcf73deba9638b391a1af6c39fa205dc9829f
ToppCellCOVID-19_Severe-Neu_0|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients

SRGN DDIT3

6.66e-04196924831243fcd680cf4821fa0246e758c3e7c13a962
ToppCell367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SRGN RSPO2

6.66e-04196926730743cf088c419ccc2d28765769fc09d3ba6a7
ToppCellsaliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SRGN DDIT3

6.66e-0419692fe8d3f45a64323947c36b127355d5940eb56c0ca
ToppCellsaliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SRGN DDIT3

6.66e-0419692526d037bb12d81f1c235c60ddc787fbad0bbad77
ToppCell367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SRGN RSPO2

6.66e-041969221dab89f3699037138a9c7a0e4dc98739a9fad9c
ToppCellcritical-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

SRGN TBCD

6.66e-0419692c861f017aa9050282aa81c5a445bae399df00e4f
ToppCellILEUM-non-inflamed-(6)_ILC-(6)_ILC1|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

SRGN TBCD

6.66e-04196928a3a63129adfbe58558af91336f81d397c291ed0
ToppCellBrain_organoid-organoid_Velasco_nature-3_mon-Radial_glial-RG|3_mon / Sample Type, Dataset, Time_group, and Cell type.

DDIT3 RSPO2

6.66e-0419692e77461ab0f909c1d22965d99f251da49f03cbb8f
ToppCellCOVID-19_Severe-Neu_0|World / 5 Neutrophil clusters in COVID-19 patients

SRGN DDIT3

6.66e-04196924fdea41ac7d84f0c52d102d87a5fce620480985e
ToppCellILEUM-inflamed-(1)_Cytotoxic_T_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

SRGN TBCD

6.66e-041969242d807605c6103fc80f038f4a351e89981533669
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Radial_glial-aRG|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.

DDIT3 RSPO2

6.66e-041969247988afe0c8fd45d4ae5df9745febc87a6e82b55
ToppCellnormal_Pleural_Fluid-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass

SRGN TBCD

6.73e-04197922bf540fa228687a71f595a807e4a2af20588a82c
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SRGN DDIT3

6.73e-0419792340ce4fef244176fb52e38ffbcbdfda5ac3467dd
ToppCellBAL-Control-cDC_5|Control / Compartment, Disease Groups and Clusters

SRGN DDIT3

6.73e-04197928a3fe59be3ed1f0254cc8c60b99c840193370efb
ToppCell343B-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

SRGN DDIT3

6.73e-0419792cd54e6ad175529327fa0372033016b3b978dd452
ToppCellsaliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SRGN DDIT3

6.73e-0419792037f5f26fa66818baa35846aa96336155e8a6f45
ToppCellParenchymal-10x5prime-Immune_Lymphocytic-T-T_CD8-MAIT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

SRGN ACP6

6.73e-0419792b8535734a61b718ff17a6a374182f30c1d3bc86f
ToppCell(5)_Fibroblasts-(5)_Fibroblast-G|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)

SRGN RSPO2

6.73e-0419792a21a710c824f9e5c7ef1674168d1ce5aef85bd35
ToppCellsaliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SRGN DDIT3

6.73e-04197923cd1c816bc7a57278b2ef615b69545356ab8f522
ToppCell390C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

SRGN DDIT3

6.80e-0419892a1c8e5c332336823c47c04e56b6d7bc8f057c9da
ToppCell356C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

SRGN DDIT3

6.80e-0419892ec115c4a5dbc54206c72140aa0c8d6a7c29c5563
ToppCellnormal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass

SRGN RSPO2

6.80e-0419892e0e47cf65774191981840b22905b2094b95abe0f
ToppCell343B-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

SRGN DDIT3

6.80e-0419892294a48ef6c0b89c7be948452cea79d23d3901e75
ToppCellSigmoid-NK_cell|Sigmoid / Region, Cell class and subclass

SRGN TBCD

6.87e-0419992653965a8bb09abcab7d275b01d361b7b4e3fdd58
ToppCellmild-Neutrophil|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SRGN DDIT3

6.87e-04199922fd5759acf49c02c5bbcc2941676216e7444d76d
ToppCellSigmoid-(0)_NK_cell|Sigmoid / shred on region, Cell_type, and subtype

SRGN TBCD

6.87e-04199925be944da7a6c5f6076ed508a64f77d90836becd7
ToppCellSigmoid-(0)_NK_cell-(00)_NK|Sigmoid / shred on region, Cell_type, and subtype

SRGN TBCD

6.87e-0419992689e8675d2d40cfb1bd200767a35dcc6664214d9
ToppCellsaliva-Mild-Moderate_progression_d12-25-Myeloid|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SRGN DDIT3

6.87e-04199929da8b48ec1c1c105fcbab6ae8f08166e7d5e8a35
ToppCellSigmoid-NK_cell-NK|Sigmoid / Region, Cell class and subclass

SRGN TBCD

6.87e-04199925aa943ef7a1764ce4e95a7163aaabe2ee89eb870
ToppCellParenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-gdT|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

SRGN TBCD

6.87e-0419992a0f1e0d1aa175c2dcc5e744fff8b56ddda5293df
ToppCellParenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CCL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SRGN DDIT3

6.87e-041999251be0e3a91d1f25454b56d55ef6342ef8e8df4e8
ToppCellmild-Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SRGN DDIT3

6.87e-0419992ca319976a7d2576186d0a98cdc93e4c2d5fe8a05
ToppCellParenchymal-10x3prime_v2-Immune_Myeloid-Mast_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

SRGN DDIT3

6.93e-042009221de2cf284c8d2aa464f3d403f0e292e1f654e0a
ToppCell390C-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

SRGN DDIT3

6.93e-042009248ca9269ee3962d13408fef12b5be120759eac52
ComputationalBreast cancer expression clusters.

DDIT3 AQR

2.37e-0321742MODULE_389
ComputationalGenes in the cancer module 207.

DDIT3 AQR

2.57e-0322642MODULE_207
ComputationalGenes in the cancer module 14.

SRGN DDIT3

6.31e-0335742MODULE_15
ComputationalDRG (dorsal root ganglia) genes.

SRGN DDIT3

7.28e-0338442MODULE_2
ComputationalCell line expressed genes.

SRGN DDIT3

9.16e-0343242MODULE_52
ComputationalFetal liver genes - metabolism and xenobiotics.

SRGN TBCD

1.00e-0245342MODULE_24
ComputationalGenes in the cancer module 15.

SRGN TBCD

1.26e-0250942MODULE_16
Drugmegestrol

SRGN ACP6

1.84e-051982CID000019090
DrugAC1L1HRV

SRGN ACP6

2.49e-052282CID000004264
Drugtifomycin

SRGN DDIT3 ACP6

8.18e-0526383CID000000298
Druglead nitrate

DDIT3 ACP6

1.42e-045282CID000024924
DrugN-methyl-N-formylhydrazine

DDIT3 ACP6

2.65e-047182CID000012962
DrugChlorpromazine

SRGN DDIT3 ACP6

7.72e-0456483ctd:D002746
Drugcisplatin

SRGN TBCD

1.01e-0313982CID000002767
DrugAC1L9OLY

DDIT3 THYN1

1.04e-0314182CID000424898
Drugcobalt(II) chloride

SRGN DDIT3

1.11e-0314682CID000024288
DrugTetracycline

SRGN DDIT3 ACP6

1.26e-0366883ctd:D013752
DrugMethyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A

SRGN DDIT3

1.67e-03179826045_UP
DrugDiethylstilbestrol [56-53-1]; Up 200; 15uM; MCF7; HT_HG-U133A

SRGN DDIT3

1.67e-03179823895_UP
DrugPiperlongumine [20069-09-4]; Up 200; 12.6uM; HL60; HG-U133A

DDIT3 AQR

1.67e-03179821764_UP
DrugDisulfiram [97-77-8]; Up 200; 13.4uM; PC3; HT_HG-U133A

DDIT3 TBCD

1.74e-03183822053_UP
DrugMonensin sodium salt [22373-78-0]; Up 200; 5.8uM; PC3; HT_HG-U133A

DDIT3 TBCD

1.78e-03185827402_UP
DrugDobutamine hydrochloride [49745-95-1]; Up 200; 11.8uM; PC3; HT_HG-U133A

DDIT3 TBCD

1.78e-03185826286_UP
DrugStrophantine octahydrate [11018-89-6]; Down 200; 5.4uM; MCF7; HT_HG-U133A

ACP6 THYN1

1.82e-03187822656_DN
DrugLY 294002; Down 200; 10uM; MCF7; HT_HG-U133A

DDIT3 AQR

1.84e-03188825224_DN
DrugEtidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; MCF7; HT_HG-U133A

DDIT3 AQR

1.84e-03188823325_DN
DrugCloperastine hydrochloride [14984-68-0]; Up 200; 11uM; MCF7; HT_HG-U133A

DDIT3 TBCD

1.86e-03189823408_UP
Drug2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A

ACP6 TBCD

1.88e-03190826199_UP
DrugDicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A

DDIT3 AQR

1.88e-03190821483_UP
DrugPhthalylsulfathiazole [85-73-4]; Down 200; 10uM; MCF7; HT_HG-U133A

DDIT3 AQR

1.88e-03190825614_DN
Drug17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A

DDIT3 TBCD

1.92e-03192821638_DN
DrugMiconazole [22916-47-8]; Up 200; 9.6uM; PC3; HG-U133A

DDIT3 TBCD

1.94e-03193821896_UP
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A

DDIT3 TBCD

1.94e-03193825602_DN
DrugBromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; PC3; HG-U133A

SRGN THYN1

1.96e-03194821925_DN
DrugClotrimazole [23593-75-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A

SRGN TBCD

1.96e-03194823166_DN
DrugPimozide [2062-78-4]; Up 200; 8.6uM; PC3; HT_HG-U133A

DDIT3 TBCD

1.96e-03194827132_UP
DrugAmikacin hydrate [37517-28-5]; Down 200; 6.6uM; PC3; HT_HG-U133A

SRGN DDIT3

1.96e-03194826715_DN
DrugAltretamine [654-05-6]; Down 200; 19uM; MCF7; HT_HG-U133A

DDIT3 AQR

1.96e-03194826467_DN
DrugClenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A

AQR TBCD

1.98e-03195825631_DN
DrugMifepristone [84371-65-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A

SRGN AQR

1.98e-03195823185_DN
DrugIpratropium bromide [22254-24-6]; Down 200; 9.8uM; MCF7; HT_HG-U133A

DDIT3 AQR

1.98e-03195822762_DN
Drugresveratrol; Up 200; 50uM; MCF7; HG-U133A

DDIT3 PCDHA10

1.98e-0319582622_UP
DrugNaphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HG-U133A

SRGN TBCD

1.98e-03195821886_DN
DrugDihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; MCF7; HT_HG-U133A

AQR TBCD

1.98e-03195827034_UP
Drugmonastrol; Up 200; 100uM; MCF7; HG-U133A

DDIT3 THYN1

2.00e-0319682627_UP
DrugRitodrine hydrochloride [23239-51-2]; Down 200; 12.4uM; MCF7; HT_HG-U133A

DDIT3 AQR

2.00e-03196825680_DN
DrugPrednisolone [50-24-8]; Down 200; 11uM; HL60; HT_HG-U133A

DDIT3 ACP6

2.00e-03196822393_DN
DrugBetazole hydrochloride; Up 200; 27uM; PC3; HT_HG-U133A

DDIT3 TBCD

2.00e-03196826344_UP
DrugDobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A

SRGN TBCD

2.00e-03196823206_DN
DrugHymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A

DDIT3 AQR

2.00e-03196823383_DN
DrugDoxylamine succinate [562-10-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A

DDIT3 AQR

2.00e-03196824819_DN
DrugPimozide [2062-78-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A

SRGN AQR

2.00e-03196823178_DN
DrugMethylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A

SRGN DDIT3

2.00e-03196823183_DN
DrugAzaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A

DDIT3 AQR

2.02e-03197823573_DN
Drugclofibrate; Down 200; 150uM; MCF7; HG-U133A

AQR TBCD

2.02e-0319782263_DN
DrugCinoxacin [28657-80-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A

DDIT3 TBCD

2.02e-03197826257_DN
DrugZaprinast [37762-06-4]; Down 200; 14.8uM; MCF7; HT_HG-U133A

SRGN AQR

2.02e-03197823226_DN
DrugRetinoic acid [302-79-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A

SRGN AQR

2.02e-03197823165_DN
DrugDiethylcarbamazine citrate [1642-54-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A

DDIT3 AQR

2.02e-03197827425_DN
DrugFosfosal [6064-83-1]; Down 200; 18.4uM; MCF7; HT_HG-U133A

AQR TBCD

2.02e-03197824823_DN
DrugClomipramine hydrochloride [17321-77-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A

SRGN TBCD

2.02e-03197823182_DN
DrugDemecarium bromide [56-94-0]; Down 200; 5.6uM; MCF7; HT_HG-U133A

AQR TBCD

2.02e-03197822773_DN
DrugDebrisoquin sulfate [581-88-4]; Down 200; 9uM; MCF7; HT_HG-U133A

SRGN AQR

2.02e-03197823207_DN
DrugNeostigmine bromide [114-80-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A

DDIT3 TBCD

2.02e-03197825335_UP
DrugMometasone furoate [83919-23-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A

DDIT3 AQR

2.02e-03197825541_UP
DrugPempidine tartrate [546-48-5]; Down 200; 13uM; HL60; HT_HG-U133A

ACP6 TBCD

2.02e-03197822172_DN
DrugBisoprolol fumarate; Down 200; 9uM; MCF7; HT_HG-U133A

AQR TBCD

2.04e-03198825348_DN
DrugTremorine dihydrochloride [300-68-5]; Down 200; 15uM; MCF7; HT_HG-U133A

SRGN DDIT3

2.04e-03198823196_DN
DrugCanrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; PC3; HT_HG-U133A

AQR ACP6

2.04e-03198822065_UP
DrugCyclopenthiazide [742-20-1]; Up 200; 10.6uM; HL60; HT_HG-U133A

ACP6 TBCD

2.04e-03198822905_UP
Drug(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A

AQR TBCD

2.04e-03198824367_DN
DrugTodralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A

DDIT3 TBCD

2.04e-03198821677_DN
DrugCephapirin sodium salt [24356-60-3]; Down 200; 9uM; HL60; HT_HG-U133A

ACP6 TBCD

2.04e-03198822730_DN
DrugDehydrocholic acid [81-23-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A

AQR TBCD

2.04e-03198825681_DN
DrugSulpiride [15676-16-1]; Down 200; 11.8uM; PC3; HG-U133A

SRGN DDIT3

2.04e-03198821887_DN
DrugBacitracin [1405-87-4]; Down 200; 2.8uM; HL60; HT_HG-U133A

ACP6 TBCD

2.04e-03198823109_DN
DrugDyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; HL60; HT_HG-U133A

DDIT3 ACP6

2.04e-03198822392_DN
DiseaseS-7-hydroxywarfarin to S-warfarin ratio measurement

SRGN AQR

2.65e-048192EFO_0803334
Diseaseneutrophil measurement

SRGN THYN1

1.25e-0317792EFO_0803548
Diseasehair color

RSPO2 TBCD

3.80e-0331192EFO_0003924
Diseasehair colour measurement

RSPO2 TBCD

1.42e-0261592EFO_0007822
DiseaseHbA1c measurement

SRGN TBCD

1.69e-0267592EFO_0004541
DiseaseLiver Cirrhosis, Experimental

SRGN THYN1

2.19e-0277492C0023893

Protein segments in the cluster

PeptideGeneStartEntry
QGRARASLCNLYNWR

AQR

1136

O60306
SQQCAQRQRWGYRRS

C22orf46

106

C9J442
WSYSQQRRQRVCSGE

PCDHA10

746

Q9Y5I2
SQNQSWNLRRECSRR

DDIT3

11

P0DPQ6
RRCQANNWTGQLSYR

C4orf54

31

D6RIA3
CQGNRWRRSKRASYV

RSPO2

21

Q6UXX9
RRARYQWVRCNPDSN

SRGN

31

P10124
QSCWSLRQRTRGRRQ

ACP6

206

Q9NPH0
QTTCWDGVRNYQARN

THYN1

86

Q9P016
WRYQRGCRSLAANLQ

TBCD

316

Q9BTW9